SHP-2 Promotes the Maturation of Oligodendrocyte Precursor Cells Through Akt and ERK1/2 Signaling In Vitro by Liu, Xiujie et al.
SHP-2 Promotes the Maturation of Oligodendrocyte
Precursor Cells Through Akt and ERK1/2 Signaling In
Vitro
Xiujie Liu
., Yuanyuan Li
., Yong Zhang, Yan Lu, Wei Guo, Peng Liu, Jiazhen Zhou, Zhenghua Xiang,
Cheng He*
Key Laboratory of Molecular Neurobiology, Institute of Neuroscience, Ministry of Education, Neuroscience Research Centre of Changzheng Hospital, Second Military
Medical University, Shanghai, China
Abstract
Background: Oligodendrocyte precursor cells (OPCs) differentiate into oligodendrocytes (OLs), which are responsible for
myelination. Myelin is essential for saltatory nerve conduction in the vertebrate nervous system. However, the molecular
mechanisms of maturation and myelination by oligodendrocytes remain elusive.
Methods and Findings: In the present study, we showed that maturation of oligodendrocytes was attenuated by sodium
orthovanadate (a comprehensive inhibitor of tyrosine phosphatases) and PTPi IV (a specific inhibitor of SHP-2). It is also
found that SHP-2 was persistently expressed during maturation process of OPCs. Down-regulation of endogenous SHP-2 led
to impairment of oligodendrocytes maturation and this effect was triiodo-L-thyronine (T3) dependent. Furthermore, over-
expression of SHP-2 was shown to promote maturation of oligodendrocytes. Finally, it has been identified that SHP-2 was
involved in activation of Akt and extracellular-regulated kinases 1 and 2 (ERK1/2) induced by T3 in oligodendrocytes.
Conclusions: SHP-2 promotes oligodendrocytes maturation via Akt and ERK1/2 signaling in vitro.
Citation: Liu X, Li Y, Zhang Y, Lu Y, Guo W, et al. (2011) SHP-2 Promotes the Maturation of Oligodendrocyte Precursor Cells Through Akt and ERK1/2 Signaling In
Vitro. PLoS ONE 6(6): e21058. doi:10.1371/journal.pone.0021058
Editor: Lin Mei, Medical College of Georgia, United States of America
Received October 20, 2010; Accepted May 18, 2011; Published June 20, 2011
Copyright:  2011 Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the National Natural Science Foundation (30970999), National Key Basic Research Program (2007CB947100,
2011CB504401), and the Ministry of Science and Technology of China (2009ZX09311-001). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: chenghe@smmu.edu.cn
. These authors contributed equally to this work.
Introduction
Myelination in vertebrates has evolved to insulate axons and
facilitate saltatory conduction of action potentials. Within the CNS,
oligodendrocytes are responsible for the formation of myelin.
Oligodendrocytes are derived from OPCs, which originate from the
ventral of the ventricular zone. OPCs proliferate, migrate to, and
spread over the CNS before differentiating into premyelinating
oligodendrocytes [1,2]. Subsequently, oligodendrocytes undergo
morphological maturation and produce myelin components.
Eventually, axons are myelinated through a complex process
orchestrated by a series of extrinsic and intrinsic regulators [3].
Many growth factors, including neuregulins, insulin-like growth
factor-I and ciliary neurotrophic factor, have been shown to
regulate oligodendrocyte differentiation through activating their
receptorsexpressedonthesurfaceofoligodendrocytes[4,5,6].Once
these corresponding receptors are activated, the intracellular signals
will betriggeredmainlythrougha networkofpathwaysregulatedby
the level of phosphorylation dependent on the opposing actions of
protein kinases and protein phosphatases [7,8]. It has been much
documented that protein kinases were critical for oligodendrocyte
differentiation [9,10,11,12]. However the role of protein phospha-
tases in this process has yet to be further investigated.
SHP-2, a Src-homology 2 domain (SH2)-containing tyrosine
phosphatase, is a widely expressed intracellular enzyme. SHP-2
has been shown to be involved in JAK/STATs, mitogen activated
protein kinase (MAPK)/ERK1/2 and Phosphatidylinositol-3-
kinase (PI3K)/Akt signaling cascade in various cell types [13]. It
was also found to bind directly to a variety of receptor tyrosine
kinases (RTKs) in response to stimulation by growth factors or
cytokines [14,15]. Recently, SHP-2 has been reported to play
crucial roles in regulation of generation, proliferation and
myelination of oligodendrocytes in vivo [16,17]. However, the
underlying mechanism remains to be clarified.
In the present study, we found that SHP-2 was persistently
expressed during developmental process of oligodendrocytes.
SHP-2 regulated the maturation of oligodendrocyte precursor
cells via Akt and ERK1/2 signaling in vitro.
Materials and Methods
Animals and reagents
SD rats were obtained from Joint Ventures Sipper BK
Experimental Animal (Shanghai, China). All animal experiments
were undertaken in accordance with the National Institute of
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the approval of Second Military Medical University Committee on
Animal Care (permission No: SCXK-HU-2007-0003). SOV and
BrdU were purchased from Sigma (St. Louis, MO). SHP-2
inhibitor (PTPi IV) was from Calbiochem (Darmstadt, Germany).
Antibodies to NG2 and MBP were purchased from Millipore
(Billerica, MA). Mouse monoclonal antibody to O4 was from
Sigma. Rabbit polyclonal antibodies to SHP-2 were from Sant
Cruz/Bioworld. Rabbit polyclonal antibodies to GFP were from
Sant Cruz. Rabbit polyclonal antibodies against pERK, ERK,
pAkt and Akt were from Cell Signaling. Antibody to GAPDH was
from Kangchen. Mouse monoclonal anti-BrdU antibody was from
Thermo and the In-Situ Cell Death Detection Kit, TMR red was
from Roche.
Primary cell culture
OPCs were isolated from SD postnatal day 1 rats as described
previously [18]. Briefly, the forebrains were removed and diced
into fragments in Hank’s buffered salt solution (HBSS) and
incubated at 37uC for 30 min with 0.125% trypsinase. Dissociated
cells were plated on poly-L-lysine (PLL)-coated tissue culture flasks
and grown at 37uC for 10 day in DMEM medium with 10% fetal
calf serum (Gibco). OPCs were collected by shaking the flask
overnight at 280 rpm at 37uC, resulting in 90% purity. For
assessing maturation, OPCs were plated on cover slides in
neurobasal medium supplemented with both B27 (2%) and
conditional medium (CM) of B104 cells for 2–5 days and
proliferated up to more than 20,000 cells per cm
2. Then, OPCs
were pre-treated with inhibitors before media were changed into
the differentiation medium. Lentivirus-mediated ShRNA trans-
fections were performed at least 3 days before differentiation
induction. In maturation assay, 30 nM T3 was added to induce
OPCs to differentiate into O4+ premyelinating oligodendrocytes
after 1 day and into MBP+ cells after 3 days.
Preparation of culture conditioned medium
Ninety percent confluent B104 cells were rinsed by incubation
with Hank’s balanced salt solution and cultured in neurobasal
Figure 1. SOV inhibits expression of MBP in oligodendrocytes in vitro. (A) Identification of purified OPCs. (B) OPCs were pre-treated with
different doses of SOV for 1 h every 24 h before the medium were changed to fresh differentiation medium without SOV. OPCs were immunostained
with anti-MBP antibody (red) 3 days after maturation induction. The total number cells were identified by Hoechst staining (blue). The culture without
SOV treatment was used as control. (C) Percentages of MBP-positive cells against the total number of cells. For each group, over 1000 cells were
analyzed. *P,0.05, **P,0.01 vs controls. (D) After induction of maturation, OPCs treated with or without SOV were lysed and immunoblotted with
antibody against MBP. GAPDH was used as a loading control. (E) Quantification of D was presented as fold of control. Results were from three
independent experiments. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0021058.g001
Figure 2. SOV inhibits morphological maturation of OPCs in vitro. (A) OPCs were pre-treated with different doses of SOV. After induction of
maturation for 1 day, cells were fixed and stained with O4 monoclonal antibody. O4-positive cells were then categorized into three types. The
representative images of cells in three categories are shown. (B) The percentages of the cells treated with or without SOV in each category were
quantified after induction of maturation. For each group, over 1000 cells were analyzed. *P,0.05, **P,0.01 vs controls. Data represent five
independent experiments.
doi:10.1371/journal.pone.0021058.g002
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and filtered with 0.22 mm filters to remove cell debris. Media were
used in OPCs amplification after dilution with the appropriate
fresh medium at different concentration.
Lentiviral vector construction and production
Lentivirus encoding shRNAs for SHP-2 were prepared by
GenePharma (Shanghai, China). The shRNA sequence is as
follows: 59-GAUUCAGAACACUGGGGAC-39, which was de-
signed according to previous report [19]. For construction of
lentiviral vector expressing SHP-2, human SHP-2 cDNA was
amplified by PCR and subcloned to pWP vectors. To produce
lentivirus containing SHP-2, HEK-293T cells were co-transfected
with pWP-SHP2 plasmid and ViraPower Packaging Mix using
Lipofectamine 2000 according to the manufacturer’s guidelines.
Western blot
Oligodendrocytes were rinsed briefly with ice-cold PBS and
lysed for 5 min in sample buffer. The cell lysates were denatured
by boiling for 10 minutes and then centrifuged for 10 min at
Figure 3. The effect of SOV on proliferation and apoptosis of the OPCs in vitro. (A) The primary cultures of OPCs were placed on PLL-
coated dishes and cultured in different concentrations of SOV for 8 h with 10 mM BrdU. Proliferated cells were labeled with anti-BrdU (green), and
cells were labeled with NG2 antibody (red). The culture without SOV was used as control and quantification was presented as fold of control. Ratio of
BrdU-labeled cells was calculated. Data shown are the mean 6 S.D. of three independent experiments. *P,0.05 vs controls. (B) Apoptotic cells were
detected by TUNEL staining (red), and total number of cells was detected with Hoechst staining (blue). The culture without SOV was used as control
and quantification was presented as fold of control. Ratio of TUNEL-labeled cells was calculated. Data shown are the mean 6 S.D. of three
independent experiments. **P,0.01 vs controls.
doi:10.1371/journal.pone.0021058.g003
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every 24 h before the medium were changed to fresh differentiation medium without PTPi IV. OPCs were immunostained with anti-MBP antibody
(red) 3 days after induction of maturation. The total number of cells was identified by Hoechst staining (blue). The culture added DMSO was used as
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Bradford method. Proteins were separated by sodium dodecyl
sulfate (SDS)-polyacrylamide gel and then transferred onto
nitrocellulose membranes. Membranes were then blocked with
5% non-fat milk in 1XTBST(Tris 10 mM, NaCl 150 mM,
Tween20 0.1%, pH 7.6) and incubated with primary antibodies.
After incubating with horseradish peroxidase (HRP)-conjugated
secondary antibodies (Kang Chen), immunoreactive bands were
visualized by chemiluminescence reagents (ECL, Pierce).
Immunohistochemistry and immunocytochemistry
Cultured cells were gently rinsed with PBS (10 mM sodium
phosphate, pH 7.4, and 150 mM NaCl) and then fixed with 4%
paraformaldehyde (PFA) for 20 min at room temperature. The
fixed cells were incubated with primary antibodies overnight at
4uC and stained with corresponding secondary antibodies. For
immunohistochemistry, animals were anesthetized and perfused
intracardially with 4% PFA in 0.1 M phosphate buffer, pH 7.2.
The brains were removed, post-fixed overnight in the same
control. (B) Percentages of MBP-positive cells against the total number of cells. For each group, over 1000 cells were analyzed. *P,0.05, **P,0.01 vs
controls. Data represent three independent experiments. (C) After induction of maturation, OPCs treated with different concentration of PTPi IV were
lysed and immunoblotted with antibody against MBP with GAPDH as a loading control. (D) Quantification of C was presented as fold of Control.
Results were from three independent experiments. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0021058.g004
Figure 5. The effect of PTPi IV on proliferation and apoptosis of the OPCs in vitro. (A) The OPCs were cultured in different concentration of
PTPi IV for 8 h with 10 mM BrdU. OPCs were labeled with NG2 antibody (red), and proliferated cells were labeled with anti-BrdU (green). The culture
without PTPi IV was used as control and quantification was presented as fold of control. Ratio of BrdU-labeled cells was calculated. Data shown are
the mean 6 S.D. of three independent experiments. (B) Apoptotic cells were detected by TUNEL staining (red), and the total number of cells were
identified by Hoechst staining (blue). The culture without PTPi IV was used as control and quantification was presented as fold of control. Ratio of
TUNEL-labeled cells was calculated. Data shown are the mean 6 S.D. of three independent experiments.
doi:10.1371/journal.pone.0021058.g005
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phosphate buffer and embedded Twenty-micro-meter frozen
sections were cut and incubated in blocking buffer containing
5% BSA and 0.5% TritonX-100 for 30 minutes and then
incubated overnight at room temperature with the primary
antibodies diluted in the same blocking buffer. After rinsing in
PBS, sections were incubated with the appropriate secondary
antibodies conjugated to fluorescein or rhodamine (Jackson
ImmunoResearch and Vector Laboratories). Hoechst 33258
(10 mg/ml; Sigma) was used as nuclear marker. Images were
obtained using the Nikon fluorescent microscope or a Leica SP2
confocal microscope.
BrdU incorporation and TUNEL assays
Proliferation assay was manipulated as described previously
[16]. Briefly, OPCs were purified and plated onto PLL-coated 24-
well culture dishes. During transfection assay, the following
supplements were added: B104 CDM or 30 nM T3. After
72 hours lentiviral-transfection, OPCs were incubated for 8 hours
with 10 mM BrdU. During inhibitors assay, cultures were changed
with the media supplemented with 30 nM T3 and 10 mM BrdU
after OPCs were pre-treated with inhibitors. After culturing for
8 hours, the preparations were gently rinsed with PBS and fixed in
4% paraformaldehyde. Paraformaldehyde was removed 20 min
later followed by three times of washing by PBS. Then, the
preparations were treated with 2N HCL for 15 min, 0.1 M
sodium borate, pH 8.5, for 15 min, and 0.2% Triton X-100 for
10 min at room temperature. Each step was followed by three
times of washing by PBS. The preparations were successively
performed according to immunocytochemical protocol. Percent-
ages of BrdU-labeled cells against total or GFP-labeled cells were
calculated. TUNEL assay was carried out using the in situ cell
death detection kit (Roche) following manufacturer’s instruction.
In brief, the specimens were fixed in 4% PFA for 30 min and then
processed for antigen retrieval with 0.1 M sodium citrate solution
at room temperature. The specimens were then incubated with
TUNEL reaction solution mixture containing terminal-deoxynu-
cleo-tidyltra-nsferase (TdT) in a humidified chamber at 37uC for
30 minutes.
RT-PCR
Total RNA was isolated using trizol reagents (Invitrogen) from
cultures. The cDNA synthesis was performed using thermoscript
RT-PCR system (Invitrogen). The following oligonucleotide
primers were used: for rat SHP-2, the forward primer was 59-
GCAGTGC-TGGGATTGGCCGGACAGGAAC-39, and the
reverse primer was 59- CAGTCAACCCCG-GCGAGCTTCT-
GAACAC-39; for rat GAPDH, the forward primer was 59-
GCATGGCCTTC-CGTGTTCCTA-39, and the reverse primer
was 59-AGTGTTGGGGGCTGAGTTGG-39;
Statistical analysis
All data are presented as mean 6 SD. Statistical analysis was
performed using ANOVA or unpaired Student’s t-test. Statistical
significance was calculated with P value of ,0.05.
Results
PTPs inhibitors suppress oligodendrocyte maturation in
vitro
Several tyrosine phosphatases have been found in the
oligodendrocytes [20]. To investigate the effect of these phospha-
tases on oligodendrocyte maturation in vitro, we used SOV, a
broad-spectrum inhibitor of tyrosine phosphatases [21], to
interrupt activities of protein tyrosine phosphatases in the
oligodendrocytes and detect their effect on oligodendrocyte
maturation. OPCs were purified and cultured on poly-L-lysine-
coated slides in neurobasal media supplemented with B27. The
purity of OPCs was estimated to be over 95% using NG2 as a
marker (Fig. 1A). The OPCs were induced to differentiate and pre-
treated with SOV for 1 h every 24 h before fresh differentiation
media were changed. The cells were immunostained with anti-
MBP antibody 3 days after induction of maturation. The total
number of cells was identified by Hoechst staining. The culture
without SOV treatment was used as the control. We found that
SOV treatment ($25 mM) resulted in a significant decrease in the
number of MBP imunopositive cells (Fig. 1B, C). Western blot
analysis further showed that SOV treatment inhibited the
expression of MBP in oligodendrocytes (Fig. 1D, E). Since
maturation of oligodendrocytes involves dynamic morphological
changes driven by cytoskeletal rearrangements, we wondered
whether SOV participates in the morphological maturation of
oligodendrocytes. The OPCs were cultured for 1 day in
differentiation media with or without SOV, and immunostained
by O4 subsequently. The representative morphology of matura-
tion were categorized into three stages (Figure 2A) as described
previously [22]. As shown in Fig. 2B, SOV treatment ($25 mM)
significantly inhibited maturation of oligodendrocytes into the
stage with high morphological complexity of processes.
Next, we performed BrdU assay to evaluate the role of SOV on
OPCs proliferation, Purified OPCs were cultured in different
concentration of SOV for 8 h with BrdU. Proliferated cells were
labeled with anti-BrdU and NG2 antibody. As shown in figure 3A,
no significant difference in ratio of BrdU positive cells was found
between low doses of SOV(#50 mM) groups and the control
group. However, proliferation of the 100 mM SOV group showed
significantly decrease. We also performed TUNEL staining to
evaluate the role of SOV in OPCs apoptosis. As shown in
figure 3B, there was no significant difference in TUNEL-positive
cells between low doses of SOV(#50 mM) treated groups and the
control except that apoptotic cells in the 100 mM SOV group
showed significantly increase. Thus, high dose of SOV group
(100 mM) inhibited both proliferation and maturation of the OPCs
and induced apoptosis. We speculated that these may be due to
the toxic effect of SOV on the cells.
PTPi IV, protein tyrosine phosphatase Inhibitor IV, acts as a
potent, reversible, competitive inhibitor of protein tyrosine
phosphatases according to the product description of Calbiochem.
Thus, we used PTPi IV to further identify the potential
phosphatase affecting oligodendrocytes maturation. The cells were
allowed to differentiate and PTPi IV was added for 6 h every 24 h
as previous described [23] before the media were changed to fresh
Figure 6. Expression of SHP-2 in oligodendrocytes in vitro and in vivo. (A) OPCs differentiated for 1, 3 and 5 days and analyzed protein
levels of SHP-2 by western blot. GAPDH and MBP were used as control. (B) Densitometry to determine levels of SHP-2 protein, quantification
presented as fold of control. Results were from three independent experiments. (C) Expression of SHP-2 in primary cultured rat OPCs. The distribution
of SHP-2 (green) and NG2 (red) or MBP (red) is shown by immunofluorescence. (D) SHP-2 expression of oligodendrocytes in brain slices. The tissue
slices from rat brain were immunostained with SHP-2 antibody (green) and markers of oligodendrocytes (red). Arrows indicate SHP-2 expression in
oligodendrocytes.
doi:10.1371/journal.pone.0021058.g006
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was used as control. OPCs were immunostained with anti-MBP
antibody 3 days after induction of maturation. The total OPCs
were identified by Hoechst staining. The culture without PTPi IV
treatment was used as the control. As shown in Fig. 4A and B,
PTPi IV significantly decreased the number of MBP positive
Figure 7. Knockdown of SHP-2 inhibits oligodendrocytes maturation. (A) RT-PCR analysis of SHP-2 mRNA transcription in OPCs infected
with lentivirus expressing ShRNAs of SHP-2 (SHP2-si), Scramble (Control-si) or blank vector (Control). GAPDH was used as an internal standard. (B)
Quantification of A, presented as fold of control. Results were from three independent experiments. **p,0.01. (C) OPCs infected with lentivirus
expressing ShRNA were immunostained with anti-MBP antibody (red) after induction of maturation for 3 days. Arrows indicate MBP+ in GFP-
expressing cells. The cells infected with Lentivirus expressing the control ShRNA and induced by T3 were used as control. (D) Percentages of MBP-
positive cells (red) against the GFP-labeled cells, over 500 cells were analyzed for each group. Data represent three independent experiments.
**p,0.01.
doi:10.1371/journal.pone.0021058.g007
Figure 8. Overexpression of SHP-2 positively regulates oligodendrocyte maturation. (A) OPCs were infected with lentivirus expressing
SHP-2. After induction of maturation for 3 days, cells were immunostained with anti-MBP antibody (red). Arrows indicate MBP+ in GFP-expressing
cells. The cells infected with Lentivirus expressing the blank vector tagged by GFP were used as control. (B) Percentages of MBP-positive cells (red)
against the total number of infected cells, over 500 cells were analyzed for each group. Data represent three independent experiments. *p,0.05. (C)
The overexpression of GFP-SHP2 in transfected OPCs were detected by western blot using GFP antibody.
doi:10.1371/journal.pone.0021058.g008
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analysis further showed that PTPi IV treatment inhibited MBP
expression in oligodendrocytes (Fig. 4C, D). We also examined the
effect of PTPi IV on proliferation and apoptosis of OPCs, OPCs
were cultured in different concentrations of PTPi IV for 8 h with
BrdU. Proliferated cells were labeled with anti-BrdU and NG2
antibody. As shown in figure 5A, no difference in ratio of BrdU
positive cells was found between PTPi IV groups and the control
group in differentiation medium. We also performed TUNEL
staining to evaluate the role of PTPi IV in OPCs apoptosis. As
shown in figure 5B, there was no significant difference in TUNEL-
positive cells after PTPi IV treatment at these concentrations.
PTPi IV has relative specific inhibitory activity on SHP-2 at 2 mM
concentration as previous described [23]. Thus, these data provide
the clue that SHP-2 may affect the oligodendrocytes maturation
without influencing proliferation and apoptosis in T3-supplement-
ed differentiation media.
SHP-2 is necessary for maturation of oligodendrocytes
To examine the role of SHP-2, we firstly detected the expression
of SHP-2 in oligodendrocytes. OPCs were cultured and allowed to
differentiate for 1, 3, or 5 days. Cell lysates were obtained and
Western blot analysis using SHP-2 antibodies was performed. As
shown in Fig. 6A and B, SHP-2 was persistently expressed during
maturation process of OPCs. Double staining for SHP-2 and NG2
or MBP revealed that SHP-2 was expressed in both precursor and
mature oligodendrocytes (Fig. 6C). To examine the expression
patterns of SHP-2 in vivo, we carried out immunohistochemistry
analysis in rat brain slices. As shown in Fig. 6D, in the cortex slices,
both NG2 and MBP were observed to merge with SHP-2,
suggesting that SHP-2 were expressed in oligodendrocytes in vitro
and in vivo.
To further confirm the specific effect of SHP-2 on OPCs
maturation, we infected primary OPCs with a lentivirus expressing
both GFP and a short-hairpin RNA (shRNA) sequence targeting
SHP-2. The expression of SHP-2 was specifically knocked down
by infection with this ShRNA, whereas the SHP-2 expression in
the control was unaffected (Fig. 7A,B). Similar to the effect of PTPi
IV, knockdown of SHP-2 reduced the number of MBP positive
cells compared to those infected with the control ShRNA
(Fig. 7C,D). Whereas, there was no significant difference in the
number of MBP positive cells between SHP-2 knockdown ShRNA
and the controls ShRNA without T3-induction (Fig. 7C,D). We
also overexpressed SHP-2 in oligodendrocytes by lentivirus
(Fig. 8C). In contrast to the effect of knockdown, overexpression
of SHP-2 significantly increased the number of MBP positive cells
in cultures supplemented with T3 (Fig. 8A,B). Next, we detected
whether SHP-2 affect OPCs proliferation, The primary cultures of
OPCs were placed on PLL-coated dishes and amplified in B104
CDM which is rich in mitogens. Then, the lentiviruses were added
into the cultures. After 72 hours lentiviral-infection, OPCs were
incubated for 8 hours with 10 mM BrdU and the following
Figure 9. The effect of SHP-2 knockdown on proliferation of the OPCs in vitro. (A, B and C) OPCs were infected with the lentivirus
expressing SHP-2 ShRNA and corresponding control. After 72 hours lentiviral-transfection, the medium was changed and the following supplements
were added: B104 CDM (B)o r3 0n MT 3( C). The basal medium (Neurobasal) was used as control (A). OPCs were incubated for 8 hours with 10 mM
BrdU. Proliferated cells were labeled with anti-BrdU (red), and cells were labeled with GFP antibody (green). (D) Quantification of A was presented as -
fold of control. The culture transfected with the blank vector was used as control. Ratio of BrdU-labeled cells was calculated. Data shown are the
mean 6 S.D. of three independent experiments. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0021058.g009
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T3. The neurobasal media was used as the control. Cells were
labeled with anti-BrdU and GFP antibody. We observed that
B104 CDM significantly increased OPCs proliferation compared
to the control (Fig. 9A, B and D). T3 slightly inhibited OPCs
proliferation (Fig. 9A, C and D). After SHP-2 knockdown, OPCs
proliferation significantly decreased in the culture supplemented
with B104 CDM (Fig. 9B and D). However, no difference in ratio
of BrdU positive cells was observed in the basal medium group
and the cells supplemented with T3 (Fig. 9A, C and D). These data
indicate that SHP-2 is required not only for OPCs proliferation by
mitogens stimulation but also for maturation induced by T3.
Akt and ERK1/2 signaling are involved in mediating the
effect of SHP-2 on oligodendrocyte maturation
Activation of the Akt and ERK1/2 are known to be crucial for
the differentiation of OPCs [8,24] and T3 has been shown to
induce the activation of Akt and ERK1/2 in human fibroblasts
and myoblasts [25,26,27]. To demonstrate that SHP-2 was
involved in regulating oligodendrocytes maturation through Akt
and ERK1/2 signaling, we detected the activation of Akt and
ERK1/2 after gene-manipulation of SHP-2 expression in OPCs.
As shown in Figure 10A, B and C, Western blot analysis revealed
that OPCs supplemented with T3 resulted in prominent activation
of both ERK1/2 and Akt, and SHP-2 overexpression increased
the T3-induced activation of Akt and ERK1/2 in the OPCs. It
seemed that the promotional effect of SHP-2 overexpression on
the activation of Akt is more significant than that on ERK1/2.
Meanwhile, after knockdown the expression of SHP-2, these
activations were significantly inhibited (Fig. 10D, E and F). To
further characterize the signaling pathways mediating the effect of
SHP-2, we examined whether these signaling pathways were
involved in T3–induced oligodendrocytes maturation. The
cultured cells were pre-treated with specific inhibitors of various
protein kinases for 30 min as previous described [28]. After pre-
treatment, the activation of Akt and ERK1/2 by T3 were
significantly reduced in the OPCs without affecting cells survival
(Fig. 11C and D). As shown in Figure 11A and B, the promoting-
effect of SHP-2 overexpression on oligodendrocyte maturation was
eliminated by pre-treatment with LY 294002, a selective PI3K
inhibitor. Meanwhile, PD98059, a selective inhibitor of MAPK,
also attenuated the acceleration of oligodendrocytes maturation by
SHP-2 overexpression. Thus, our data supported the notion that
SHP-2 may be involved in regulating T3-induced oligodendro-
cytes maturation via Akt and ERK1/2 signaling.
Discussion
Several studies have been reported that protein phosphatases
exist in oligodendrocytes and function as a regulator for
differentiation and maturation of oligodendrocytes [29,30].
Genetic deletions of SHP-1, the phosphatase and tensin homolog
deleted on chromosome 10 (PTEN) and episilon have been shown
to negatively regulate myelination [31,32,33]. Recently, receptor-
like protein tyrosine phosphatase a (PTPa) has been shown to
promote oligodendrocyte differentiation and myelination through
regulating Fyn signaling [29]. Furthermore, Zhu et al reported
that maturation and myelination of oligodendrocytes were
compromised in SHP-2 conditional mutants [17]. In the present
study, we firstly used SOV to examine the effect of comprehensive
inhibition of tyrosine phosphatases on the development of OPCs.
We found that SOV significantly inhibited the maturation of
OPCs in vitro. Moreover, we found that the maturation of
oligodendrocytes was significantly hindered by PTPi IV treatment.
These results were confirmed by SHP-2 knockdown. Our data
provided evidences that SHP-2 positively regulates oligodendro-
cytes maturation. It has been reported that SHP-2 regulates the
phosphatidylinositide 39-kinase/Akt pathway and suppresses
caspase 3-mediated apoptosis in fibroblasts and myoblasts [34].
However, no significant apoptosis increase was observed 3 days
after induction of maturation in PTPi IV-treated OPCs. We
speculated that this may be due to that T3 promotes survival of
OPCs in vitro.
Kuo et al. reported that tyrosine phosphatases SHP-1 and SHP-
2 had unique and opposing roles in oligodendrocyte development.
They found that SHP-2 depletion did not prevent oligodendrocyte
differentiation in vitro [16], which is inconsistent with our results.
It is likely that the differences of the culture system may account
for these conflicting results. In our study, T3 was added into the
differentiation media to induce oligodendrocytes maturation. We
found that there was no significant effect on oligodendrocytes
maturation when SHP-2 was knocked down without T3 induction,
suggesting that SHP-2 may play a key role in T3-induced OPCs
maturation.
SHP-2 has been shown to be involved in a number of signaling
pathways. It has been reported that the activation of Ras/Raf/
ERKs signaling pathway is positively regulated by SHP-2 [35].
Additionally, SHP-2 regulates growth factor-mediated PI3K/Akt
pathway. Ectopic expression of SHP-2 in U87MG gliobastoma
cells elevated EGF-induced Akt phosphorylation. Deletion of
SHP-2 in mouse fibroblasts reduced phosphorylation of Akt and
ERK1/2 [34,36]. Both Akt and ERK1/2 signaling have been
demonstrated to play key roles in differentiation of oligodendro-
cytes [8,24]. In this study, we found that the phosphorylation levels
of Akt and ERK1/2 in T3-induced differentiating oligodendro-
cytes were greatly increased. More importantly, the promotional
effect of SHP-2 overexpression on oligodendrocyte maturation was
eliminated by treatment with specific inhibitors of Akt and ERK1/
2, indicating the involvement of these signaling pathways in
maturation of oligodendrocytes. Thyroid hormone has been well
documented to be a key regulator in oligodendrocytes by
triggering the onset of differentiation [37,38,39]. Moreover,
cytosolic thyroid hormone receptors can interact with the p85a
regulatory subunit of PI3K and activate PI3K/Akt [26]. T3 can
also induce activation of MAPK/ERK via putative G-protein-
coupled receptor [27]. In our study, SHP-2 knockdown in
oligodendrocytes was found to significantly down-regulate the
activation of ERK1/2 and Akt induced by T3. Conversely, SHP-2
overexpression increased the T3-induced activation of Akt and
ERK1/2 in the OPCs. Our data strongly suggested that SHP-2
may function at the downstream of T3 signaling and promote
oligodendrocytes maturation through facilitating activation of Akt
Figure 10. SHP-2 is involved in T3-induced activation of Akt and ERK1/2 in OPCs. (A) OPCs were infected with lentivirus expressing SHP-2
using blank vector as control. Activation of Akt and ERK1/2 in oligodendrocytes was assessed with western blot after T3 stimulation in transfected
OPCs. (B, C) Quantification of A with densitometric analysis was presented as fold of control. Results were from three independent experiments.
*p,0.05 and **p,0.01. (D) Activation of Akt and ERK1/2 in oligodendrocytes were assessed with western blot after T3 stimulation in OPCs
transfected with SHP-2 ShRNA or blank vector. (E, F) Quantification of D with densitometric analysis was presented as fold of control. Results were
from three independent experiments. *p,0.05 and **p,0.01.
doi:10.1371/journal.pone.0021058.g010
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PLoS ONE | www.plosone.org 14 June 2011 | Volume 6 | Issue 6 | e21058and ERK1/2 signaling. However, the detail molecular mechanism
underlying SHP-2 involved in this process should be further
detected.
Purified population of OPCs have an intrinsic timing mecha-
nism that controls the number of cell divisions before entering cell
differentiation, while disruption of mitogenic signaling causes
OPCs to exit cell cycle and differentiate prematurely. Recent study
reported that SHP-2 knockdown decreased OPCs proliferation
[16]. Thus, it is important to determine whether the reduction in
the number of MBP+ cells by SHP-2 ShRNA is secondary to cell
cycle defects. In our proliferation assay, we observed that SHP-2
knockdown significantly decreased OPCs proliferation in the
culture supplemented with B104 CDM which is rich in mitogens
such as platelet-derived growth factor (PDGF) and et al [40].
However, no difference in ratio of BrdU positive cells was
observed in both the basal and T3-supplemented media system.
Similarly, we also found no significant changes of OPCs
proliferation after PTPi IV inhibitor treatment in T3-supplement-
ed differentiation system. OPCs proliferation showed slightly
decrease after T3 treatment which is consistent with the previous
report [38]. Thus, we speculate that SHP-2 may play various roles
in OPCs development and these effects were affected by the
distinct extracellular stimulations. The development of oligoden-
drocytes in vivo results from sequential series of events including
proliferation, migration, differentiation, myelination and et al.
Each of these processes is regulated by various signals [3]. Our
results showed that SHP-2 was persistently expressed in oligoden-
drocytes from early stage to terminal differentiation. These data
indicated that SHP-2 is required not only for OPCs proliferation
by mitogens stimulation but also for maturation induced by
promotional differentiation factors.
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